Saratov JOURNAL of Medical and Scientific Research
Home

The impact of the new coronavirus infection on the state of arterial bed in healthy individuals and patients with arterial hypertension

Year: 2024, volume 20 Issue: №3 Pages: 278-283
Heading: Cardiology Article type: Original article
Authors: Pavlenko K.I., Avdeeva I.V.
Organization: Penza State University
Summary:

Objective: to identify indicators of arterial stiffness that change after COronaVlrus Disease-2019 (COVID-19). Material and methods. Included were 112 people examined before and after the start of the new coronavirus infection (NCI) pandemic: healthy individuals (groups "H" and "H/COVID +") and patients with arterial hypertension (AH) (groups "AH" and "AH/COVID+"). An isolated comparative study was carried out in groups of healthy people and patients with hypertension. Results. Individuals in the "H/COVID+" group had higher levels of non-high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and more low values of high-density lipoprotein cholesterol (p=0.038; p=0.032; p=0.006) when compared with group "H". According to ABPM data, between the "AH" and "AH/Covid+" groups it was revealed difference at night level of reflected wave transit time (RWTT). An increase in cardio-ankle vascular index (L-/CAVI.,) in healthy persons and subjects with AH (p=0.001; p=0.004). In patients "H/COVID+" group higher values of pulse wave velocity in the aorta (PVW), elastic arteries type (R/L - PVW) and biological age (p=0.001; p=0.005; p=0.001) were registered. Conclusion. In healthy individuals who have had COVID-19, lipid profile abnormalities were noted, as well as an increase in L-/CAVI., when compared with the group of those who were not ill. In patients with AH after COVID-19, a negative change in the majority of indicators of arterial stiffness was noted.

Keywords: volume sphygmography, COVID-19, arterial stiffness, arterial hypertension

Bibliography:
1. Lukyanov MM, Andreenko EYu, Martsevich SYu, et al. Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry. Cardiovascular Therapy and Prevention. 2023; 22 (10): 3757. DOI: 10.15829/1728-8800-2023-3757
2. Giannis D, Allen SL, Tsang J, et al. Postdischarge throm-boembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021; 137 (20): 2838-47. DOI: 10.1182/blood. 2020010529
3. Vidya G, Sowganthikashri A, Madhuri T, et al. Arterial stiffness and COVID-19: potential association with diabetes, hypertension and obesity: A cross sectional study. Maedica (Bucur). 2023; 18 (3): 447-54. DOI: 10.26574/maedica.2023.18.3.447
4. Arutyunov GP, Tarlovskaya El, Arutyunov AG, et al. Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up). Russian Journal of Cardiology. 2023; 28 (4): 5424. DOI: 10.15829/1560-4071-2023-5424
5. Gu Т, Chu Q, Yu Z, et al. History of coronary heart disease increased the mortality rate of patients with COVID-19: A nested case-control study. BMJ Open. 2020; 10 (9): e038976. DOI: 10.1136/bmjopen-2020-038976
6. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398 (10304): 957-80. DOI: 10.1016/S0140-6736(21)01330-1
7. Gumerov RM, Gareeva DF, Davtyan PA, et al. Serum biomarkers of cardiovascular complications in COVID-19. Russian Journal of Cardiology. 2021; 26 (2S): 4456. DOI: 10.15829/1560-4071-2021-4456
8. Bunova SS, Okhotnikova PI, Skirdenko YuP, et al. COVID-19 and cardiovascular comorbidity: novel approaches to reduce mortality. Cardiovascular Therapy and Prevention. 2021; 20 (4): 2953. DOI: 10.15829/1728-8800-2021-2953
9. Gameil MA, Marzouk RE, Elsebaie AH, et al. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021; 11 (1):74. DOI: 10.1186/s43066-021-00144-1
10. Wrona M, Skrypnik D. New-onset diabetes mellitus, hypertension, dyslipidaemia as sequelae of COVID-19 infection-systematic review. Int J Environ Res Public Health. 2022; 19 (20): 13280. DOI: 10.3390/ijerph192013280
11. Dennis A, Wamil M.Alberts J.etal; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021; 11 (3): e048391. DOI: 10.1136/bmjo-pen-2020-048391
12. Podrug M, Koren P, Drazic Maras E, et al. Long-term adverse effects of mild COVID-19 disease on arterial stiffness, and systemic and central hemodynamics: A pre-post study. J Clin Med. 2023; 12 (6): 2123. DOI: 10.3390/jcm12062123
13. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 5 (2): 1417-18. DOI: 10.1016/S0140-6736(20)30937-5
14. Rodilla E, Lopez-Carmona MD, Cortes X, et al; SEMI-COVID-19 Network. Impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain. Hypertension. 2021; 77 (3): 856-67. DOI: 10.1161/HYPERTENS IONAHA.120.16563
15. Ikonomidis I, Lambadiari V, Mitrakou A, et al. Myocardial work and vascular dysfunction are partially improved at 12 months after COVID-19 infection. Eur J Heart Fail. 2022; 24 (4): 727-9. DOI: 10.1002/ejhf.2451
16. Jannasz I, Pruc M, Rahnama-Hezavah M, et al. The impact of COVID-19 on carotid-femoral pulse wave velocity: A systematic review and meta-analysis. J Clin Med. 2023; 12 (17): 5747. DOI: 10.3390/jcm12175747
17. Ratchford SM, Stickford JL, Province VM, et al. Vascular alterations among young adults with SARS-CoV-2. Am J Physiol Heart Circ Physiol. 2021; 320 (1): H404-10. DOI: 10.1152/ajpheart.00897.2020
18. Can Y, Kocayigit I, Kocayigit H, et al. Ongoing effects of SARS-CoV-2 infection on arterial stiffness in healthy adults. Angi-ology. 2023; 75 (2): 116-21. DOI: 10.1177/00033197231183227
19. Badaras I, Laucyte-Cibulskiene A. Vascular aging and COVID-19. Angiology. 2023; 74 (4): 308-16. DOI: 10.1177/00033197221121007
20. Vasilieva IN, Chesnikova Al, Klimenkova OS, et al. Evaluation of the effectiveness of drug treatment in patients with arterial hypertension and insomnia. South Russian Journal of Therapeutic Practice. 2021; 2 (4): 49-59. DOI: 10.21886/2712-8156-2021-2-4-49-59

AttachmentSize
2024_03_278-283.pdf617.39 KB
All articles of the authors: Pavlenko K.I.

No votes yet